VeraCyte Lands $65,000,000 New Financing Round

  • Feed Type
  • Date
    10/30/2013
  • Company Name
    VeraCyte
  • Mailing Address
    7000 Shoreline Court South San Francisco, CA 94080
  • Company Description
    Veracyte (NASDAQ: VCYT) is pioneering the emerging field of molecular cytology. We are developing molecular tests designed to improve the diagnostic accuracy of cytology samples, thereby helping to increase the utility of these minimally invasive procedures as an alternative to surgical biopsy.
  • Website
    http://www.veracyte.com
  • Transaction Type
    IPO
  • Transaction Amount
    $65,000,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes are on file with company statements at the SEC.
  • M&A Terms

By posting a comment, you agree to our terms and conditions.